Nexalin Technology Inc NXL Q1 2026 Earnings EPS Misses Estimates as PreRevenue Company Intensifies RD Spend ABSI Q1 2026 Earnings EPS Beats Estimates Amid Continued Drug Discovery Progress ASPS Q1 2026 Earnings EPS Exceeds Estimates by 349 Shares Surge RDWR Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Revvity Q1 2026 Earnings Solid EPS Beat Amidst Cost Discipline Pathward Financial Inc CASH Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Underlying Strength